Literature DB >> 7680738

Is there an acute-phase response in steady-state sickle cell disease?

A Singhal1, J F Doherty, J G Raynes, K P McAdam, P W Thomas, B E Serjeant, G R Serjeant.   

Abstract

Metabolic and serum changes during steady-state homozygous sickle cell (SS) disease are consistent with an acute-phase response and raise the possibility that inflammation occurs in SS disease even during the steady state. To test this hypothesis, we measured concentrations of acute phase reactants in patients with SS disease, in patients with sickle cell haemoglobin C (SC) disease, and in normal (AA) control subjects. The concentrations of C-reactive protein and serum amyloid A were increased above 10 mg/L and 5 mg/L, respectively (our definition of an acute-phase response) in 18% (26/143) of subjects with SS disease even when they were symptom free, in 17% (6/35) of subjects with SC disease, and in 1% (1/80) of AA controls (p < 0.001). We suggest that subclinical vaso-occlusion may generate a covert inflammatory response and that the cytokine mediators of this response may contribute to the metabolic abnormalities and growth failure in sickle cell disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680738     DOI: 10.1016/0140-6736(93)90418-g

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

1.  Reference distributions for the positive acute phase proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.

Authors:  Patrick B Walter; Ellen B Fung; David W Killilea; Qing Jiang; Mark Hudes; Jacqueline Madden; John Porter; Patricia Evans; Elliott Vichinsky; Paul Harmatz
Journal:  Br J Haematol       Date:  2006-10       Impact factor: 6.998

3.  Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease.

Authors:  Jacqueline M Hibbert; Lewis L Hsu; Sam J Bhathena; Ikovwa Irune; Bismark Sarfo; Melissa S Creary; Beatrice E Gee; Ali I Mohamed; Iris D Buchanan; Ahmad Al-Mahmoud; Jonathan K Stiles
Journal:  Exp Biol Med (Maywood)       Date:  2005-01

4.  Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease.

Authors:  J Stuart; P C Stone; N O Akinola; J R Gallimore; M B Pepys
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

5.  Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease.

Authors:  K A Nath; J P Grande; J J Haggard; A J Croatt; Z S Katusic; A Solovey; R P Hebbel
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease.

Authors:  Ashaunta Tumblin; Anitaben Tailor; Gerard T Hoehn; A Kyle Mack; Laurel Mendelsohn; Lita Freeman; Xiuli Xu; Alan T Remaley; Peter J Munson; Anthony F Suffredini; Gregory J Kato
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

7.  Cardiovascular autonomic dysfunction in sickle cell anemia: a possible risk factor for sudden death?

Authors:  J C Romero Mestre; A Hernández; O Agramonte; P Hernández
Journal:  Clin Auton Res       Date:  1997-06       Impact factor: 4.435

8.  Plasma proteins in children with trichuris dysentery syndrome.

Authors:  E S Cooper; D D Ramdath; C Whyte-Alleng; S Howell; B E Serjeant
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

9.  Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises.

Authors:  Suba Krishnan; Yamaja Setty; Suhita G Betal; Vaidyula Vijender; Koneti Rao; Carlton Dampier; Marie Stuart
Journal:  Br J Haematol       Date:  2009-12-08       Impact factor: 6.998

10.  C-reactive protein and interleukin-6 are decreased in transgenic sickle cell mice fed a high protein diet.

Authors:  David R Archer; Jonathan K Stiles; Gale W Newman; Alexander Quarshie; Lewis L Hsu; Phouyong Sayavongsa; Jennifer Perry; Elizabeth M Jackson; Jacqueline M Hibbert
Journal:  J Nutr       Date:  2008-06       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.